Panion & Bf Biotech Inc.
Research Panion & Bf Biotech Inc. (1760.TW) on Bullrun: market cap TWD 4.64B, P/E 21.6, dividend yield 3.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1760.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 4.64B
- P/E21.6
- Dividend yield3.8%
- Financial periodQ2 2026
- RevenueTWD 511.84M
- Net incomeTWD 39.11M
- Free cash flowTWD 37.04M
- Gross margin50.6%
Valuation Snapshot
latest market cap is TWD 4.64B; P/E is 21.6; dividend yield is 3.8%.
Peer valuation comparison
Latest P/E is 21.64x versus a Healthcare sector median of 21.8x.
Latest dividend yield is 3.77% versus a Healthcare sector median of 2.4% (57.1% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 4.64B | 21.6 | 3.3% | 1.8 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.8 TWD, yield 3.8%.
About Panion & Bf Biotech Inc.
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products.
ETFs that hold Panion & Bf Biotech Inc.
US-listed ETFs
Panion & Bf Biotech Inc. is held by 10 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Vanguard ESG International Stock ETF (VSGX) | <0.01% | 0.10% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Panion & Bf Biotech Inc.'s market cap?
Panion & Bf Biotech Inc.'s market capitalization is TWD 4.64B.
What is Panion & Bf Biotech Inc.'s P/E ratio?
Panion & Bf Biotech Inc.'s price-to-earnings (P/E) ratio is 21.6.
Does Panion & Bf Biotech Inc. pay a dividend?
Panion & Bf Biotech Inc. has a dividend yield of 3.8%.
What does Panion & Bf Biotech Inc. do?
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc.